Iroquois Capital Management, LLC 13D/13G Filings for Artelo Biosciences, Inc. (ARTL)

Iroquois Capital Management, LLC 13D and 13G filings for Artelo Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-23
4:36 pm
Sale
2021-12-31 13G Artelo Biosciences, Inc.
ARTL
Iroquois Capital Management, LLC 1,111
0.240%
-9,111decrease
(-89.13%)
Filing
2020-10-19
3:25 pm
Purchase
2020-10-14 13G Artelo Biosciences, Inc.
ARTL
Iroquois Capital Management, LLC 10,222
6.670%
10,222increase
(New Position)
Filing